Home › BECTON, DICKINSON AND COMPANY › BD Difco™ Neisseria Meningitidis Antiserum Group W135

BD Difco™ Neisseria Meningitidis Antiserum Group W135

BECTON, DICKINSON AND COMPANY · Model 222531 · UDI-DI 00382902225317

GTJ Prescription

510(k) clearances

Adverse events

Recalls

Facilities

Description

Vial N Meningitidis Antiserum Grp W135

Recalls

Date	Firm	Reason
2026-07-17	Remel Europe Ltd.	Certain lots of Neisseria meningitidis Gp C 2ml/VL, R30166901, are not performing to IFU criteria not positive to ATCC13102 within 60 Seconds.
2007-09-06	BD Diagnostic Systems / Lee Laboratories	Exhibits cross reactivity with Neisseria meningitides Group W135.
2007-09-06	BD Diagnostic Systems / Lee Laboratories	Exhibits cross reactivity with Neisseria meningitides Group W135.
2007-09-06	BD Diagnostic Systems / Lee Laboratories	Exhibits cross reactivity with Neisseria meningitides Group W135
2007-09-06	BD Diagnostic Systems / Lee Laboratories	Exhibits cross reactivity with Neisseria meningitides Group W135

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API key Read the docs

Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.